Fiano Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-12-2024
- Paid Up Capital ₹ 0.60 M
as on 23-12-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 26.56%
(FY 2020)
- Profit 109.67%
(FY 2020)
- Ebitda 146.08%
(FY 2020)
- Net Worth 7.15%
(FY 2020)
- Total Assets 58.05%
(FY 2020)
About Fiano Life Sciences
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnanpayyalika, Pratheesh Nanthikat, Philip Naduvathara, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304KL2017PTC050968
- Company No.
050968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kottayam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Fiano Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Philip Naduvathara  | Managing Director | 06-Nov-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnanpayyalika | Director | 06-Nov-2017 | Current |
| Pratheesh Nanthikat | Director | 06-Nov-2017 | Current |
| Thekke Prasanthan | Director | 06-Nov-2017 | Current |
| Dayanandan | Director | 06-Nov-2017 | Current |
Financial Performance of Fiano Life Sciences.
Fiano Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 26.56% increase. The company also saw a substantial improvement in profitability, with a 109.67% increase in profit. The company's net worth moved up by a moderate rise of 7.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fiano Life Sciences?
Unlock access to Fiano Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fiano Life Sciences?
Unlock and access historical data on people associated with Fiano Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fiano Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fiano Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
